RENAISSANCE TECHNOLOGIES LLC

Position in FDMT — 4D Molecular Therapeutics, Inc.

CIK 1037389 NEW YORK, NY

Position in FDMT

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$8,173,820

+$2,790,173 QoQ

Shares Held

614,573

+6.3% QoQ

Ownership

0.851%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#20

of 158 holders

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,951,130,026 across 312 Biotechnology names. FDMT ranks #56 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,173,820	614,573	+6.3%	Shares	Sole	2026-08-13
2026-03-31	$5,383,647	578,265	+12.7%	Shares	Sole	2026-05-14
2025-12-31	$3,846,750	512,900	+63.8%	Shares	Sole	2026-02-12
2025-09-30	$2,721,586	313,186	+168.7%	Shares	Sole	2025-11-13
2025-06-30	$432,411	116,553	+496.1%	Shares	Sole	2025-08-13
2025-03-31	$63,156	19,553	-72.0%	Shares	Sole	2025-05-14
2024-03-31	$2,224,879	69,833	+406.0%	Shares	Sole	2024-05-13
2023-03-31	$237,222	13,800	-89.2%	Shares	Sole	2023-05-12
2022-12-31	$2,845,101	128,100	+85.4%	Shares	Sole	2023-02-13
2022-09-30	$555,564	69,100	-73.4%	Shares	Sole	2022-11-14
2022-06-30	$1,812,008	259,600	+275.7%	Shares	Sole	2022-08-12
2022-03-31	$1,044,792	69,100	+54.2%	Shares	Sole	2022-05-13
2021-12-31	$982,912	44,800	—	Shares	Sole	2022-02-11
No filing history on record for this holder in this stock.